Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology

Circulating Tumor Cells and Biomarkers: Implications for Personalized Targeted Treatments for Metastatic Breast Cancer

(2010) James M. Reuben et al.   Breast Journal

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells

(2010) H. K. Lin et al.   CLINICAL CANCER RESEARCH

Monitoring Drug-Induced  H2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells

(2010) L. H. Wang et al.   CLINICAL CANCER RESEARCH

Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer

(2010) Daniel P. Silver et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Biomarker Analyses Using Circulating Tumor Cells

(2010) Elizabeth A. Punnoose et al.   PLoS One

Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

(2010) S. L. Stott et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

(2009) C. Liedtke et al.   ANNALS OF ONCOLOGY

Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis

(2009) Nikolas H. Stoecklein et al.   INTERNATIONAL JOURNAL OF CANCER

Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer

(2009) Zhenbin Chen et al.   PLoS One

Platinum-based chemotherapy in triple-negative breast cancer

(2008) B. Sirohi et al.   ANNALS OF ONCOLOGY

Is There a Role for Circulating Tumor Cells in the Management of Breast Cancer?

(2008) D. F. Hayes et al.   CLINICAL CANCER RESEARCH

Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial

(2008) J.-Y. Pierga et al.   CLINICAL CANCER RESEARCH

Triple-Negative Breast Cancer: Risk Factors to Potential Targets

(2008) B. P. Schneider et al.   CLINICAL CANCER RESEARCH

Review: Biological relevance of disseminated tumor cells in cancer patients

(2008) Sabine Riethdorf et al.   INTERNATIONAL JOURNAL OF CANCER

Monitoring the Response of Circulating Epithelial Tumor Cells to Adjuvant Chemotherapy in Breast Cancer Allows Detection of Patients at Risk of Early Relapse

(2008) Katharina Pachmann et al.   JOURNAL OF CLINICAL ONCOLOGY

Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells

(2008) Anieta M. Sieuwerts et al.   JNCI-Journal of the National Cancer Institute

Detection of Mutations inEGFRin Circulating Lung-Cancer Cells

(2008) Shyamala Maheswaran et al.   NEW ENGLAND JOURNAL OF MEDICINE

Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients

(2008) Rachel E Payne et al.   PHARMACOGENOMICS

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications

(2007) F. Nole et al.   ANNALS OF ONCOLOGY